Nail psoriasis affects a large number of patients with psoriasis and has a major psychosocial impact. Furthermore, it may be regarded as a predictor of more severe forms of psoriasis and early sign of psoriatic arthritis. The clinical presentations vary depending on the structure affected (nail matrix or nail bed), the nail lesions may range from minor to severe, but they are not specific. Treatment is a challenge, in most cases the lesions being resistant to therapy. We present a rare case of psoriasis with nail onset in a 59-year-old woman. The nail involvement confined to the fingernails was severe, with significant impairment of the patient's quality of life. Conventional therapies failed to improve the nail lesions, but a marked improvement was achieved under etanercept therapy.
Introduction
Psoriasis is a chronic immune-mediated disorder affecting about 2% of the general population. The pathogenic mechanisms involved in the development of psoriasis lesions are related to the activation of the immune system, which leads to the release of proinflammatory cytokines, such as TNF alpha, IL17, 12, 23, etc. These mediators of inflammation stimulate processes such as excessive keratinocyte proliferation and angiogenesis, promoting the occurrence of psoriasis lesions (1, 2) .
Most patients with psoriasis develop nail lesions during the course of the disease, the prevalence of nail psoriasis among patients with psoriasis ranging between 10 and 78%, with a mild male predominance (3) .
Approximately 1-5% of patients present nail lesions without skin manifestations (4) . However, studies have shown that many patients who initially had only nail involvement developed skin or joint lesions later (5) .
Nail psoriasis involves the fingernails more frequently than the toenails (3). Clinical signs vary depending on the structure affected. If the lesions are confined to the nail matrix, pitting (cupuliform depressions), leukonychia, red spots in the lunula, or nail crumbling may occur. Nail bed lesions lead to onycholysis, subungual hyperkeratosis, splinter hemorrhages, oil drop discoloration, and nail thickening.
Nail pitting is the most common sign encountered in nail psoriasis (6) (7) (8) . These changes are not specific and may also occur in other disorders (9) .
NAPSI (spell out the first time?) is the most commonly used index for assessing the severity of nail psoriasis. The method involves the division of the nail into four quadrants by drawing imaginary lines (a vertical and a horizontal line) and the evaluation of the matrix and nail bed lesions in each quadrant (3, 9) .
Treatment is difficult due to the low penetration of topical treatments in the nail, the pathologic changes further contributing to this problem. As a result, systemic therapy is often necessary (10).
Case Report
A 59-year-old woman was admitted to our clinic for For example, patients with nail psoriasis who received 15mg/weekly of methotrexate showed a reduction in the NAPSI score of43.3% after 24 weeks of treatment. In the same study,patients treated with cyclosporine showed a 37% mean improvement in the NAPSI score (21 (25) . The efficacy of etanercept in nail psoriasis has also been supported by other studies (7, 26, 27) . In our case, there was a rapid response to etanercept with a significant reduction in the NAPSI score.
Bardazzi et al. concluded that adalimumab, infliximab, ustekinumab and etanercept exhibit similar efficacy in the treatment of nail psoriasis. They also postulated that patients with nail lesions reach PASI 75 slower than those without nail involvement (28) .
Conclusions
We present a case of psoriasis vulgaris with nail onset, characterized by severe nail lesions and a significant impact on the patient's quality of life, with a marked improvement following the treatment with etanercept and poor response to classical therapies with acitretin and methotrexate. Nail lesions are common among psoriasis patients and are associated with a significant psychosocial impact. Treatment often remains a significant challenge.
